ciprofloxacin has been researched along with Streptococcal Infections in 72 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Streptococcal Infections: Infections with bacteria of the genus STREPTOCOCCUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The clinical efficacy and tolerability of ciprofloxacin orally administered at the dosage of 250 mg twice a day was evaluated in 25 patients affected by acute bacterial pharyngotonsillitis." | 9.06 | Oral ciprofloxacin for treatment of acute bacterial pharyngotonsillitis. ( D'Errico, G; Esposito, S; Montanaro, C, 1990) |
| "The study was undertaken to compare the safety and efficacy of twice-daily ciprofloxacin for 3 days with standard 7 day therapy with either co-trimoxazole or nitrofurantoin in the treatment of women with acute, uncomplicated urinary tract infections (UTI)." | 5.09 | A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. ( Briefer, C; Echols, RM; Iravani, A; Klimberg, I; Kowalsky, SF; Munera, C, 1999) |
| "The clinical efficacy and tolerability of ciprofloxacin orally administered at the dosage of 250 mg twice a day was evaluated in 25 patients affected by acute bacterial pharyngotonsillitis." | 5.06 | Oral ciprofloxacin for treatment of acute bacterial pharyngotonsillitis. ( D'Errico, G; Esposito, S; Montanaro, C, 1990) |
| "Ciprofloxacin in a low dosage of 250 mg twice a day was applied in the treatment of bacterial infections of the skin." | 3.67 | [The effectiveness of ciprofloxacin in bacterial skin infections]. ( Blenk, H; Meisel, C, 1988) |
| "Oral ciprofloxacin is a cost-effective prophylactic agent for high-risk ERCP." | 2.69 | Antibiotic prophylaxis for ERCP: a comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients. ( Alveyn, CG; Davis, AJ; Kolios, G; Robertson, DA, 1998) |
| " Drug-related adverse events were reported by 8." | 2.69 | A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections. ( Jasovich, A; Neto, W; Nicodemo, AC; Robledo, JA, 1998) |
| "Ciprofloxacin therapy was well tolerated; ceftriaxone therapy was discontinued in two patients (8%) due to adverse reactions (intramuscular pain and drug fever)." | 2.67 | A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections. ( Gruninger, RP; Guay, DR; Hirata-Dulas, CA; Peterson, PK; Stein, DJ, 1991) |
| "We are reporting a rare case of brain abscess caused by Group G Streptococcus in a 12 year-old female child who presented with neurological symptoms." | 1.40 | Group G Streptococci in association with brain abscess: a rare occurrence. ( Chakravarthy, H; Lingaiah, BB; Madappa, BP; Raja, V; Subramani, P, 2014) |
| " FQs at proper dosage can be effective against S." | 1.39 | Effect of subinhibitory concentrations of fluoroquinolones on biofilm production by clinical isolates of Streptococcus pyogenes. ( Balaji, K; Pandian, SK; Thenmozhi, R, 2013) |
| "We report a case of bacteremia and severe sepsis caused by S." | 1.36 | Mycotic abdominal aortic aneurysm due to Streptococcus suis: a case report. ( Arworn, S; Laohapensang, K; Rutherford, RB, 2010) |
| "Levofloxacin was also quite active, inhibiting 98-100% of the isolates at concentrations < or = 2 micrograms/ml." | 1.30 | Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin. ( Jones, RN; Pfaller, MA, 1997) |
| "Levofloxacin was investigated against viridans group streptococci in vitro and in rats with experimental aortic endocarditis." | 1.30 | Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci. ( Caldelari, I; Entenza, JM; Glauser, MP; Moreillon, P, 1999) |
| "Penicillin G prophylaxis was associated with an increased incidence of fever of unknown origin and more frequent isolation of aerobic gram-negative bacteria in surveillance cultures." | 1.29 | Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy. ( de Jong, M; de Jong, P; Kuijper, E; van der Lelie, J, 1993) |
| "Against respiratory tract infections with K." | 1.28 | In vivo evaluation of NM441, a new thiazeto-quinoline derivative. ( Kimura, K; Kise, M; Kitano, M; Matsuda, M; Nishino, T; Otsuki, M; Ozaki, M; Segawa, J; Shibata, K; Tomii, Y, 1991) |
| "Relapse is common even after apparently adequate therapy and may be seen in up to 25% of cases that involve streptomycin-resistant strains." | 1.28 | Relapsing native-valve enterococcal endocarditis: a unique cure with oral ciprofloxacin combination drug therapy. ( Dietrich, KA; Dixon, WA; Landau, SW; Miller, WC; Sacher, HL; Sacher, ML, 1991) |
| "Norfloxacin was ineffective at 200 mg/kg per day against E." | 1.27 | In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones. ( Bower, RR; Chu, DT; Fernandes, PB; Jarvis, KP; Ramer, NR; Shipkowitz, N, 1986) |
| "Ciprofloxacin was effective and safe therapy of infections due to Gram-negative bacteria resistant to many of the currently available oral and parenteral agents." | 1.27 | Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosa. ( Neu, HC; Scully, BE, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (13.89) | 18.7374 |
| 1990's | 25 (34.72) | 18.2507 |
| 2000's | 22 (30.56) | 29.6817 |
| 2010's | 15 (20.83) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyamoto, T | 1 |
| Matsumoto, J | 1 |
| Chiba, K | 1 |
| Egawa, H | 1 |
| Shibamori, K | 1 |
| Minamida, A | 1 |
| Nishimura, Y | 1 |
| Okada, H | 1 |
| Kataoka, M | 1 |
| Fujita, M | 1 |
| Duesberg, CB | 1 |
| Malhotra-Kumar, S | 2 |
| Goossens, H | 2 |
| McGee, L | 1 |
| Klugman, KP | 1 |
| Welte, T | 1 |
| Pletz, MW | 1 |
| Montes, M | 1 |
| Tamayo, E | 1 |
| Orden, B | 1 |
| Larruskain, J | 1 |
| Perez-Trallero, E | 2 |
| Haebich, D | 1 |
| Kroll, HP | 1 |
| Lerchen, HG | 1 |
| Pires, R | 1 |
| Ardanuy, C | 2 |
| Rolo, D | 1 |
| Morais, A | 1 |
| Brito-Avô, A | 1 |
| Gonçalo-Marques, J | 1 |
| Liñares, J | 2 |
| Santos-Sanches, I | 1 |
| Sellami, M | 1 |
| Mnejja, M | 1 |
| Masmoudi, M | 1 |
| Maalej, F | 1 |
| Charfeddine, I | 1 |
| Ghorbel, A | 1 |
| de Magalhães Rodrigues Martins, CM | 1 |
| Alves, BG | 1 |
| Monteiro, CP | 1 |
| Pinheiro, ESC | 1 |
| Feckinghaus, MA | 1 |
| Paranhos, LG | 1 |
| Dos Santos, MV | 1 |
| Balaji, K | 1 |
| Thenmozhi, R | 1 |
| Pandian, SK | 1 |
| Blennow, O | 1 |
| Ljungman, P | 1 |
| Sparrelid, E | 1 |
| Mattsson, J | 1 |
| Remberger, M | 1 |
| Yao, J | 1 |
| Shang, K | 1 |
| Huang, J | 1 |
| Ran, W | 1 |
| Kashif, J | 1 |
| Wang, L | 1 |
| Subramani, P | 1 |
| Raja, V | 1 |
| Lingaiah, BB | 1 |
| Madappa, BP | 1 |
| Chakravarthy, H | 1 |
| Lutz, P | 1 |
| Nischalke, HD | 1 |
| Krämer, B | 1 |
| Goeser, F | 1 |
| Kaczmarek, DJ | 1 |
| Schlabe, S | 1 |
| Parcina, M | 1 |
| Nattermann, J | 1 |
| Hoerauf, A | 1 |
| Strassburg, CP | 1 |
| Spengler, U | 1 |
| Beck, N | 1 |
| Folia, M | 1 |
| Mahy, S | 1 |
| Duvillard, C | 1 |
| Chanteret, C | 1 |
| Lecomte, H | 1 |
| Gazzano, E | 1 |
| Piroth, L | 1 |
| Romanet, P | 1 |
| Van Heirstraeten, L | 1 |
| Lammens, C | 1 |
| Chapelle, S | 1 |
| de la Campa, AG | 1 |
| Balsalobre, L | 1 |
| Marimón, JM | 1 |
| Fenoll, A | 1 |
| Laohapensang, K | 1 |
| Rutherford, RB | 1 |
| Arworn, S | 1 |
| Maeda, Y | 2 |
| Murayama, M | 1 |
| Goldsmith, CE | 2 |
| Coulter, WA | 2 |
| Mason, C | 2 |
| Millar, BC | 2 |
| Dooley, JS | 1 |
| Lowery, CJ | 2 |
| Matsuda, M | 2 |
| Rendall, JC | 1 |
| Elborn, JS | 1 |
| Moore, JE | 2 |
| Dooley, JSG | 1 |
| Kuźniar, TJ | 1 |
| Kasibowska-Kuźniar, K | 1 |
| Grable, I | 1 |
| Esrafilzadeh, D | 1 |
| Razal, JM | 1 |
| Moulton, SE | 1 |
| Stewart, EM | 1 |
| Wallace, GG | 1 |
| Schelenz, S | 1 |
| Nwaka, D | 1 |
| Hunter, PR | 1 |
| Donnenfeld, ED | 1 |
| O'Brien, TP | 2 |
| Solomon, R | 1 |
| Perry, HD | 1 |
| Speaker, MG | 1 |
| Wittpenn, J | 1 |
| Entenza, JM | 2 |
| Vouillamoz, J | 1 |
| Glauser, MP | 2 |
| Moreillon, P | 2 |
| Barequet, IS | 1 |
| Denton, P | 1 |
| Osterhout, GJ | 1 |
| Tuli, S | 1 |
| Albertí, S | 1 |
| Cortés, G | 1 |
| García-Rey, C | 1 |
| Rubio, C | 1 |
| Baquero, F | 1 |
| García-Rodríguez, JA | 1 |
| Bouza, E | 1 |
| Aguilar, L | 1 |
| Otuonye, NM | 1 |
| Odunukwe, NN | 1 |
| Idigbe, EO | 1 |
| Imosemi, OD | 1 |
| Smith, SI | 1 |
| Chigbo, RC | 1 |
| Bamidele, M | 1 |
| Oparaugo, CT | 1 |
| Mafe, AG | 1 |
| Musa, AZ | 1 |
| Orscheln, RC | 1 |
| Johnson, DR | 1 |
| Olson, SM | 1 |
| Presti, RM | 1 |
| Martin, JM | 1 |
| Kaplan, EL | 1 |
| Storch, GA | 1 |
| Alonso, R | 1 |
| Mateo, E | 1 |
| Galimand, M | 1 |
| Garaizar, J | 1 |
| Courvalin, P | 1 |
| Cisterna, R | 1 |
| Draenert, R | 1 |
| Kunzelmann, M | 1 |
| Roggenkamp, A | 1 |
| Hellers, J | 1 |
| Bogner, JR | 1 |
| Rivera, A | 1 |
| Rebollo, M | 1 |
| Sánchez, F | 1 |
| Navarro, F | 1 |
| Miró, E | 1 |
| Mirelis, B | 1 |
| Coll, P | 1 |
| Chee, SP | 1 |
| Bacsal, K | 1 |
| West, JC | 1 |
| Guss, J | 1 |
| Kazahaya, K | 1 |
| Al-Shakarchi, F | 1 |
| Win, A | 1 |
| Evers, ML | 1 |
| Chmel, H | 1 |
| Ohl, CA | 1 |
| Sullivan, N | 1 |
| Paparello, S | 1 |
| Peter, JV | 1 |
| Abraham, OC | 1 |
| George, S | 1 |
| Brahmadathan, KN | 1 |
| Mathai, D | 1 |
| McWhinney, PH | 2 |
| Patel, S | 1 |
| Whiley, RA | 1 |
| Hardie, JM | 1 |
| Gillespie, SH | 1 |
| Kibbler, CC | 1 |
| de Jong, P | 1 |
| de Jong, M | 1 |
| Kuijper, E | 1 |
| van der Lelie, J | 1 |
| Kitzis, MD | 1 |
| Goldstein, FW | 1 |
| Ishida, N | 1 |
| Acar, JF | 1 |
| Ferraro, AL | 1 |
| Mortensen, JE | 1 |
| Blecker, DL | 1 |
| Phengvath, C | 1 |
| Kaufman, SC | 1 |
| Laird, JA | 1 |
| Cooper, R | 1 |
| Beuerman, RW | 1 |
| Pfaller, MA | 1 |
| Jones, RN | 1 |
| Mulder, JG | 1 |
| Kosterink, JG | 1 |
| Degener, JE | 1 |
| Davis, AJ | 1 |
| Kolios, G | 1 |
| Alveyn, CG | 1 |
| Robertson, DA | 1 |
| Uystepruyst, P | 1 |
| Tellier, E | 1 |
| Dardenne, B | 1 |
| Darimont, M | 1 |
| Nicodemo, AC | 1 |
| Robledo, JA | 1 |
| Jasovich, A | 1 |
| Neto, W | 1 |
| Prenna, M | 1 |
| Montanari, MP | 1 |
| Mingoia, M | 1 |
| Biavasco, F | 1 |
| Ripa, S | 1 |
| Varaldo, PE | 1 |
| Kerr, KG | 1 |
| Armitage, HT | 1 |
| Iravani, A | 1 |
| Klimberg, I | 1 |
| Briefer, C | 1 |
| Munera, C | 1 |
| Kowalsky, SF | 1 |
| Echols, RM | 1 |
| Caldelari, I | 1 |
| Jayaraman, S | 1 |
| Al-Nahhas, AM | 1 |
| Vivian, G | 1 |
| Gilbert, TJ | 1 |
| Hughes, PM | 1 |
| Persson, L | 1 |
| Vikerfors, T | 1 |
| Sjöberg, L | 1 |
| Engervall, P | 1 |
| Tidefelt, U | 1 |
| Rodríguez-Avial, I | 1 |
| Rodríguez-Avial, C | 1 |
| Picazo, JJ | 1 |
| Dhawan, B | 1 |
| Khan, U | 1 |
| Das, BK | 1 |
| Mathur, P | 1 |
| Pandhi, RK | 1 |
| Kapil, A | 1 |
| Ozaki, M | 1 |
| Tomii, Y | 1 |
| Kimura, K | 1 |
| Segawa, J | 1 |
| Kitano, M | 1 |
| Kise, M | 1 |
| Shibata, K | 1 |
| Otsuki, M | 1 |
| Nishino, T | 1 |
| Sacher, HL | 1 |
| Miller, WC | 1 |
| Landau, SW | 1 |
| Sacher, ML | 1 |
| Dixon, WA | 1 |
| Dietrich, KA | 1 |
| Pérez-Fontán, M | 1 |
| Rosales, M | 1 |
| Fernández, F | 1 |
| Moncalián, J | 1 |
| Fernández-Rivera, C | 1 |
| Alonso, A | 1 |
| Valdés, F | 1 |
| Hirata-Dulas, CA | 1 |
| Stein, DJ | 1 |
| Guay, DR | 1 |
| Gruninger, RP | 1 |
| Peterson, PK | 1 |
| Esposito, S | 1 |
| D'Errico, G | 1 |
| Montanaro, C | 1 |
| Dekker, AW | 1 |
| Rozenberg-Arska, M | 1 |
| Verdonck, LF | 1 |
| Gordon, JJ | 1 |
| Kauffman, CA | 2 |
| Mitchell, D | 1 |
| Duncan, I | 1 |
| Brook, A | 1 |
| Collignon, P | 1 |
| Collins, MS | 1 |
| Hector, RF | 1 |
| Roby, RE | 1 |
| Edwards, AA | 1 |
| Ladehoff, DK | 1 |
| Dorsey, JH | 1 |
| Peterson, LR | 1 |
| Moody, JA | 1 |
| Fasching, CE | 1 |
| Gerding, DN | 1 |
| Zervos, MJ | 1 |
| Bacon, AE | 1 |
| Patterson, JE | 1 |
| Schaberg, DR | 1 |
| Gargallo, D | 1 |
| Moros, M | 1 |
| Coll, R | 1 |
| Esteve, M | 1 |
| Parés, J | 1 |
| Xicota, MA | 1 |
| Guinea, J | 1 |
| Meisel, C | 1 |
| Blenk, H | 1 |
| Fernandes, PB | 1 |
| Chu, DT | 1 |
| Bower, RR | 1 |
| Jarvis, KP | 1 |
| Ramer, NR | 1 |
| Shipkowitz, N | 1 |
| Fernandez-Guerrero, M | 1 |
| Rouse, MS | 1 |
| Henry, NK | 1 |
| Geraci, JE | 1 |
| Wilson, WR | 1 |
| Scully, BE | 1 |
| Neu, HC | 1 |
1 review available for ciprofloxacin and Streptococcal Infections
| Article | Year |
|---|---|
Infectious keratitis after photorefractive keratectomy.
Topics: Adult; Ciprofloxacin; Corneal Ulcer; Cross Infection; Drug Therapy, Combination; Eye Infections, Bac | 2003 |
6 trials available for ciprofloxacin and Streptococcal Infections
| Article | Year |
|---|---|
Noninferiority field trial for evaluation of efficacy of ciprofloxacin associated with internal teat sealant as dry-off protocol.
Topics: Animals; Anti-Bacterial Agents; Bismuth; Brazil; Cattle; Cephalosporins; Ciprofloxacin; Corynebacter | 2019 |
Antibiotic prophylaxis for ERCP: a comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bile; C | 1998 |
A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Female; Huma | 1998 |
A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Infective Age | 1999 |
A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections.
Topics: Administration, Oral; Aged; Aged, 80 and over; Bronchitis; Ceftriaxone; Ciprofloxacin; Cross Infecti | 1991 |
Oral ciprofloxacin for treatment of acute bacterial pharyngotonsillitis.
Topics: Administration, Oral; Adult; Aged; Ciprofloxacin; Clinical Trials as Topic; Drug Administration Sche | 1990 |
65 other studies available for ciprofloxacin and Streptococcal Infections
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Drug Interactions; Fluoroquinolones; Male; Mice; Micro | 1990 |
Interspecies recombination occurs frequently in quinolone resistance-determining regions of clinical isolates of Streptococcus pyogenes.
Topics: Anti-Bacterial Agents; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Gene Tran | 2008 |
Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.
Topics: Adult; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genes, Ba | 2010 |
Arginine-pyrimidine conjugates with therapeutic and prophylactic activity in lethal bacterial infections.
Topics: Animals; Anti-Bacterial Agents; Arginine; Bacterial Infections; Cross Infection; Drug Interactions; | 2009 |
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Protei | 2010 |
[The complicated acute bacterial parotitis in adults].
Topics: Acute Disease; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxi | 2017 |
Effect of subinhibitory concentrations of fluoroquinolones on biofilm production by clinical isolates of Streptococcus pyogenes.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Se | 2013 |
Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Infective Agents; Bacteremia; Candidiasis; Child; Chil | 2014 |
Overexpression of an ABC transporter and mutations of GyrA, GyrB, and ParC in contributing to high-level ciprofloxacin resistance in Streptococcus suis type 2.
Topics: Animals; Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Ciprofloxacin; DNA Gyrase; DNA To | 2014 |
Group G Streptococci in association with brain abscess: a rare occurrence.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Brain; Brain Abscess; Child; C | 2014 |
Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Ciprofloxacin; Cross Infection; Drug | 2017 |
[Acute group A beta-hemolytic streptococcus membranous laryngotracheobronchitis in an adult].
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; | 2008 |
Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigens, Bacterial; Aza Compound | 2009 |
Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Child; Child, Preschool; Ciprofloxacin; Drug Resis | 2009 |
Mycotic abdominal aortic aneurysm due to Streptococcus suis: a case report.
Topics: Aneurysm, Infected; Animals; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Arthritis, Infectiou | 2010 |
Molecular characterization and phylogenetic analysis of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE gene loci in viridans group streptococci isolated from adult patients with cystic fibrosis.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Cystic Fibrosis; DNA Gyrase; DNA Topoisomerase IV; DNA, | 2011 |
Comparison of minimum inhibitory concentration by broth microdilution testing versus standard disc diffusion testing in the detection of penicillin, erythromycin and ciprofloxacin resistance in viridans group streptococci.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Se | 2011 |
Parotid abscess in a patient with obstructive sleep apnea treated with continuous positive airway pressure therapy.
Topics: Abscess; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; | 2012 |
Multifunctional conducting fibres with electrically controlled release of ciprofloxacin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Delayed-Action Preparations; Electric Conductivity; Escherichi | 2013 |
Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacteremia; Cancer Care Facilities; Ciprofloxacin; Drug Resistance, Bacterial | 2013 |
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; En | 2004 |
Treatment of experimental bacterial keratitis with topical trovafloxacin.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Biological Availability; Ciprofloxacin; Col | 2004 |
Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity.
Topics: Adolescent; Adult; Anti-Infective Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Ca | 2005 |
Aetiological agents of vaginitis in Nigerian women.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Female; HIV Seropositivity; Humans; Middle | 2004 |
Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bact | 2005 |
Clonal spread of pediatric isolates of ciprofloxacin-resistant, emm type 6 Streptococcus pyogenes.
Topics: Bacterial Proteins; Child; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; | 2005 |
Infected cat-bite wound treated successfully with moxifloxacin after failure of parenteral cefuroxime and ciprofloxacin.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Bites and Stings; Cats; Cefuroxime; Ciprofloxacin; Fe | 2005 |
Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain.
Topics: Amino Acid Substitution; Anti-Infective Agents; Antigens, Bacterial; Bacterial Outer Membrane Protei | 2005 |
Endophthalmitis after microincision cataract surgery.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Ba | 2005 |
Informed consent: hospital may have duty to obtain informed consent. Rogers v. T.J. Samson Community Hospital, 276 F. 3d 228 (6th Cir. 2002).
Topics: Ciprofloxacin; Connective Tissue; Humans; Informed Consent; Male; Medical Waste Disposal; Streptococ | 2002 |
Antibiotic-resistant Staphylococcus aureus in community-acquired pediatric neck abscesses.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Com | 2007 |
Initial therapy for suppurative microbial keratitis in Iraq.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Eye Infections, Bacterial; Eye Infe | 2007 |
Stevens-Johnson syndrome presumably induced by ciprofloxacin.
Topics: Adult; Ciprofloxacin; Humans; Male; Penicillin G; Stevens-Johnson Syndrome; Streptococcal Infections | 1994 |
Streptococcus sanguis bacteremia during ciprofloxacin therapy of a diabetic foot ulcer.
Topics: Bacteremia; Ciprofloxacin; Clindamycin; Diabetes Mellitus, Type 1; Diabetic Foot; Drug Resistance, M | 1994 |
Toxic strep syndrome.
Topics: Cefazolin; Cellulitis; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Middle Aged; Shock, S | 1993 |
Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Humans; Microbial | 1993 |
Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Bacteremia; Ciprofloxacin; Humans; Leukemia, Myeloid, Acute; Mid | 1993 |
SYN987, SYN1193, and SYN1253, new quinolones highly active against gram-positive cocci.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbia | 1995 |
The antimicrobial susceptibility of Streptococcus pyogenes isolates from the Philadelphia area.
Topics: Anti-Bacterial Agents; Cephalothin; Ciprofloxacin; Clindamycin; Erythromycin; Humans; Microbial Sens | 1995 |
Diagnosis of bacterial contact lens related keratitis with the white-light confocal microscope.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Contact Lenses, Extended-Wear; Cornea; Eye Infections, | 1996 |
Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; In Vitro | 1997 |
The relationship between the use of flucloxacillin, vancomycin, aminoglycosides and ciprofloxacin and the susceptibility patterns of coagulase-negative staphylococci recovered from blood cultures.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Coagul | 1997 |
[Reiter syndrome: apropos of a case].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthri | 1998 |
Antistaphylococcal and antistreptococcal killing kinetics of ciprofloxacin, ofloxacin, sparfloxacin, and trovafloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbia | 1998 |
Activity of quinolones against viridans group streptococci isolated from blood cultures of patients with haematological malignancy.
Topics: Adult; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Hematologic N | 1999 |
Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci.
Topics: Animals; Anti-Infective Agents; Catheterization; Ceftriaxone; Ciprofloxacin; Endocarditis, Bacterial | 1999 |
Demonstration of spinal osteomyelitis with Ga-67 citrate, Tc-99m MDP, and Tc-99m ciprofloxacin with provisionally negative results on MRI.
Topics: Aged; Ciprofloxacin; Citrates; False Negative Reactions; Female; Gallium; Humans; Lumbar Vertebrae; | 2000 |
Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; | 2000 |
[In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin].
Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Drug Resistance; Drug Resistance, M | 2001 |
Group B streptococcal bacteremia in an adult: a case report from India.
Topics: Adult; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Female; Humans; India; Streptococcal Infect | 2001 |
In vivo evaluation of NM441, a new thiazeto-quinoline derivative.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Ciprofloxacin; Dioxolanes; Dogs; Drug Evaluati | 1991 |
Relapsing native-valve enterococcal endocarditis: a unique cure with oral ciprofloxacin combination drug therapy.
Topics: Adult; Ampicillin; beta-Lactamases; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Endoca | 1991 |
Ciprofloxacin in the treatment of gram-positive bacterial peritonitis in patients undergoing CAPD.
Topics: Administration, Oral; Ciprofloxacin; Gram-Positive Bacterial Infections; Humans; Injections, Intrape | 1991 |
Prevention of bacteremias caused by alpha-hemolytic streptococci by roxithromycin in patients treated with intensive cytotoxic treatment.
Topics: Acute Disease; Adult; Agranulocytosis; Amphotericin B; Antineoplastic Combined Chemotherapy Protocol | 1990 |
Superinfection with Streptococcus pneumoniae during therapy with ciprofloxacin.
Topics: Ciprofloxacin; Humans; Male; Middle Aged; Pneumonia; Pneumonia, Pneumococcal; Pseudomonas Infections | 1990 |
Streptococcus faecalis arthritis.
Topics: Amoxicillin; Arthritis, Infectious; Ciprofloxacin; Drug Therapy, Combination; Enterococcus faecalis; | 1989 |
Treatment of CAPD peritonitis with oral ciprofloxacin.
Topics: Administration, Oral; Ciprofloxacin; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1989 |
[Prevention of gram-negative and gram-positive infections with 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection with intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].
Topics: Animals; Bacterial Infections; Burns; Ciprofloxacin; Combined Modality Therapy; Female; Immunoglobul | 1987 |
In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model.
Topics: Amikacin; Animals; Azlocillin; Ciprofloxacin; Disease Models, Animal; Drug Synergism; Drug Therapy, | 1987 |
Enterococcal superinfection in patients treated with ciprofloxacin.
Topics: Adult; Aged; Ciprofloxacin; Enterococcus faecalis; Humans; Kidney Failure, Chronic; Male; Pseudomona | 1988 |
Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats.
Topics: Animals; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacteria; Chemical Phenomena; Chemis | 1988 |
[The effectiveness of ciprofloxacin in bacterial skin infections].
Topics: Administration, Oral; Bacterial Infections; Ciprofloxacin; Drug Administration Schedule; Erysipelas; | 1988 |
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enterobacteriaceae In | 1986 |
In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis.
Topics: Animals; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Pen | 1987 |
Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosa.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacterial Infections; Ciprofloxacin; Drug Resi | 1986 |